<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T00:29:05Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/16989" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/16989</identifier><datestamp>2026-10-18T21:13:07Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>From aquatic plant to therapeutic prospect: LC-MS/MS-guided phytochemical profiling and in vitro antidiabetic, anticholinesterase and molecular insights into Myriophyllum spicatum L.</dc:title><dc:creator>Civas, Ayse</dc:creator><dc:creator>Gunes, Ferhat</dc:creator><dc:creator>Ozer, Elif Beyza</dc:creator><dc:creator>Imad Abdulqader, Amenah</dc:creator><dc:creator>Akyuz, Beyzanur</dc:creator><dc:creator>Yuca, Hafize</dc:creator><dc:creator>Aydin, Bilge</dc:creator><dc:creator>Karakaya, Songul</dc:creator><dc:subject>Myriophyllum spicatum</dc:subject><dc:subject>vanillic acid</dc:subject><dc:subject>Alzheimer's disease</dc:subject><dc:subject>diabetes</dc:subject><dc:subject>LC-MS/MS</dc:subject><dc:subject>molecular docking</dc:subject><dc:subject>ANTIOXIDANT ACTIVITY</dc:subject><dc:subject>DOCKING</dc:subject><dc:subject>Chemistry, Applied</dc:subject><dc:subject>Chemistry, Medicinal</dc:subject><dc:subject>Chemistry</dc:subject><dc:subject>Pharmacology &amp; Pharmacy</dc:subject><dc:description>Myriophyllum spicatum L. methanolic extract was examined through integrated biochemical, phytochemical, computational analyses. The extract exhibited strong alpha-glucosidase inhibitory activity with an IC50 value of 198.54 &amp; micro;g/mL, demonstrating markedly higher potency than reference inhibitor acarbose (IC50= 4738.12 &amp; micro;g/mL), while no inhibitory activity was detected against alpha-amylase under tested conditions. In anticholinesterase assays, extract showed acetylcholinesterase inhibition with an IC50 value of 9.70 &amp; micro;g/mL, whereas standard inhibitor donepezil exhibited a significantly stronger activity (IC50= 0.30 &amp; micro;g/mL). No inhibitory effect was observed against butyrylcholinesterase for the extract, while donepezil displayed potent inhibition (IC50= 15.40 &amp; micro;g/mL). Extract showed strong ABTS center dot+ scavenging activity (85.7% at 40 &amp; micro;g/mL) but weak DPPH center dot activity (25.6% at 25 &amp; micro;g/mL), suggesting higher affinity for hydrophilic radicals. High total phenolic, flavonoid and tannin contents correlated with antioxidant potential. LC-MS/MS revealed thirteen phenolics, mainly vanillic acid, gallic acid and cyanidin-3-O-glucoside. Docking studies supported selective alpha-glucosidase binding of vanillic acid.</dc:description><dc:publisher>TAYLOR &amp; FRANCIS LTD</dc:publisher><dc:date>2026</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/16989</dc:identifier><dc:identifier>https://doi.org/10.1080/14786419.2026.2690074</dc:identifier><dc:identifier>1478-6419</dc:identifier><dc:language>en</dc:language><dc:relation>NATURAL PRODUCT RESEARCH</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/16989</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>